Quantitative intratumoural microdistribution and kinetics of 131I-huA33 antibody in patients with colorectal carcinoma

EJNMMI Research

Table 1 Patient and tumour characteristics according to assigned huA33 dose level

Patient no.	huA33 antibody dose level (mg/m²)	Sex	Age (years)	Location of tumour resection or biopsy	Reason for operation	Tumour volume (cm³)^a
1	0.25	M	63	Liver	Bx	270
2	0.25	F	68	Lung	M	37
3	0.25	M	56	Liver	Bx	48
4	1	M	61	Liver	Bx	132
5	1	F	52	Liver	M	26
6	1	M	66	Liver	M	2,099
7	5	M	62	Colon	P	4
8	5	F	48	Liver	Bx	1,770
9	5	F	60	Liver	Bx	135
10	10	F	39	Liver	M	80
11	10	M	59	Liver	Bx	39
12	10	F	49	Liver	Bx	131

^aTotal volume of tumour identified and measured on CT scan, or at pathology (Pt. 7). Bx, biopsy at time of intrahepatic artery port insertion; M, metastectomy; P, surgery for primary colon cancer.